TRPV1 and neoplasm: We noted that following SCH58261 treatment, the CGRP signal did not alter in TRPV1+ nerves surrounding tumor xenograft (Fig. 3a, b), yet significantly enhanced in intra-tumoral nociceptors (Fig. 3a, c).